Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. - Lindholm,LH.; Ibsen,H.; Dahlöf,B. (Lancet, 2002)